Hamid Nickho

866 total citations · 1 hit paper
18 papers, 589 citations indexed

About

Hamid Nickho is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Hamid Nickho has authored 18 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Hamid Nickho's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Extracellular vesicles in disease (3 papers). Hamid Nickho is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Extracellular vesicles in disease (3 papers). Hamid Nickho collaborates with scholars based in Iran, Australia and United Kingdom. Hamid Nickho's co-authors include Leili Aghebati‐Maleki, Mehdi Yousefi, Morteza Motallebnezhad, Pooya Farhangnia, Ali‐Akbar Delbandi, Jafar Majidi, Behzad Baradaran, Hossein Khorramdelazad, Babak Bakhshinejad and Ali Aghebati‐Maleki and has published in prestigious journals such as Frontiers in Immunology, Comprehensive Reviews in Food Science and Food Safety and Journal of Hematology & Oncology.

In The Last Decade

Hamid Nickho

16 papers receiving 583 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current and future immunotherapeutic approaches in pancreatic cancer treatment

2024 86 citations Pooya Farhangnia, Hossein Khorramdelazad et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hamid Nickho Iran	12	297	141	125	121	83	18	589
Yuejie Zhu China	19	497 1.7×	135 1.0×	108 0.9×	306 2.5×	56 0.7×	68	1.0k
Shuangyou Liu China	13	197 0.7×	286 2.0×	34 0.3×	94 0.8×	162 2.0×	31	676
Almohanad A. Alkayyal Saudi Arabia	12	273 0.9×	374 2.7×	134 1.1×	321 2.7×	38 0.5×	29	903
Caitlin D. Lemke United States	15	344 1.2×	176 1.2×	63 0.5×	474 3.9×	25 0.3×	30	894
Adil Akyildiz United States	7	501 1.7×	112 0.8×	39 0.3×	204 1.7×	25 0.3×	7	735
Zhen Yan China	14	296 1.0×	78 0.6×	51 0.4×	96 0.8×	19 0.2×	44	610
S Bass United States	8	386 1.3×	88 0.6×	127 1.0×	121 1.0×	57 0.7×	11	739
Suzanne M. Gignac Germany	16	306 1.0×	136 1.0×	43 0.3×	174 1.4×	81 1.0×	38	697
Zhenyu Wu China	14	391 1.3×	85 0.6×	28 0.2×	64 0.5×	31 0.4×	49	652
Richard Stillion United Kingdom	7	205 0.7×	47 0.3×	47 0.4×	321 2.7×	23 0.3×	9	714

Countries citing papers authored by Hamid Nickho

Since Specialization

Citations

This map shows the geographic impact of Hamid Nickho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Nickho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Nickho more than expected).

Fields of papers citing papers by Hamid Nickho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Nickho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Nickho. The network helps show where Hamid Nickho may publish in the future.

Co-authorship network of co-authors of Hamid Nickho

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Nickho. A scholar is included among the top collaborators of Hamid Nickho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Nickho. Hamid Nickho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Esparvarinha, Mojgan, et al.. (2025). Role of exosomes in cancer: from diagnosis to therapy. Discover Oncology. 16(1). 2045–2045.

Nedaeinia, Reza, Simin Najafgholian, Rasoul Salehi, et al.. (2024). The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review. Cell Death Discovery. 10(1). 380–380. 34 indexed citations

Nickho, Hamid, et al.. (2024). High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Pathological Features in Patients with Pancreatic Ductal Adenocarcinoma. Iranian Journal of Allergy Asthma and Immunology. 23(3). 257–271.

Farhangnia, Pooya, Hossein Khorramdelazad, Hamid Nickho, & Ali‐Akbar Delbandi. (2024). Current and future immunotherapeutic approaches in pancreatic cancer treatment. Journal of Hematology & Oncology. 17(1). 40–40. 86 indexed citations breakdown →

Farhangnia, Pooya, et al.. (2023). SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. Frontiers in Immunology. 14. 1174138–1174138. 35 indexed citations

Nejad, Asieh Emami, et al.. (2023). The role of microRNAs involved in the disorder of blood–brain barrier in the pathogenesis of multiple sclerosis. Frontiers in Immunology. 14. 11 indexed citations

Esparvarinha, Mojgan, Hamid Nickho, Leili Aghebati‐Maleki, et al.. (2022). Understanding main pregnancy complications through animal models. Journal of Reproductive Immunology. 153. 103676–103676. 4 indexed citations

Esparvarinha, Mojgan, et al.. (2022). Dominant immune cells in pregnancy and pregnancy complications: T helper cells (TH1/TH2, TH17/Treg cells), NK cells, MDSCs, and the immune checkpoints. Cell Biology International. 47(3). 507–519. 26 indexed citations

Jazayeri, Mir Hadi, et al.. (2020). Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR). Cancer Immunology Immunotherapy. 69(9). 1833–1840. 30 indexed citations

10.

Barati, Meisam, Fardin Javanmardi, Masoumeh Jabbari, et al.. (2020). Techniques, perspectives, and challenges of bioactive peptide generation: A comprehensive systematic review. Comprehensive Reviews in Food Science and Food Safety. 19(4). 1488–1520. 73 indexed citations

11.

Barati, Meisam, Masoumeh Jabbari, Hamid Nickho, et al.. (2020). Regulatory T Cells in Bioactive Peptides-Induced Oral Tolerance; a Two-Edged Sword Related to the Risk of Chronic Diseases: A Systematic Review. Nutrition and Cancer. 73(6). 956–967. 7 indexed citations

12.

Aghebati‐Maleki, Leili, Vahid Younesi, Behzad Baradaran, et al.. (2017). Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies. SLAS DISCOVERY. 22(4). 408–417. 18 indexed citations

13.

Esparvarinha, Mojgan, Hamid Nickho, Hamed Mohammadi, et al.. (2017). The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases. Biomedicine & Pharmacotherapy. 91. 632–644. 25 indexed citations

14.

Barati, Meisam, Mehdi Yousefi, Mehrangiz Ebrahimi‐Mameghani, et al.. (2017). Oryzatensin-stimulated PBMCs Increase Cancer Progression In-vitro.. PubMed. 16(2). 120–126. 3 indexed citations

15.

Motallebnezhad, Morteza, Vahid Younesi, Leili Aghebati‐Maleki, et al.. (2016). Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells. Tumor Biology. 37(11). 14841–14850. 6 indexed citations

16.

Motallebnezhad, Morteza, Leili Aghebati‐Maleki, Farhad Jadidi‐Niaragh, et al.. (2016). The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies. Tumor Biology. 37(9). 11711–11721. 39 indexed citations

17.

Aghebati‐Maleki, Leili, Babak Bakhshinejad, Behzad Baradaran, et al.. (2016). Phage display as a promising approach for vaccine development. Journal of Biomedical Science. 23(1). 66–66. 167 indexed citations

18.

Nickho, Hamid, et al.. (2016). Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor. Bioengineered. 8(5). 501–510. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact